FG
BSX icon

Foresight Group’s Boston Scientific BSX Stock Holding History

Foresight Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37M Buy
126,468
+37,125
+42% +$2.02M 0.97% 36
2026
Q1 		$5.61M Buy
+89,343
New +$7.15M 0.99% 34

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Foresight Group's BSX Position: Q2 2026 in Review

Foresight Group increased its Boston Scientific (BSX) stake by 42% in Q2 2026, buying an estimated $2.02M and bringing the position to 126,468 shares worth $5.37M. The position accounts for 0.97% of the portfolio, ranked #36.

Foresight Group first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.61M in Q1 2026. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Foresight Group held 126,468 shares of Boston Scientific worth $5.37M as of Q2 2026.
  • Foresight Group bought 37,125 Boston Scientific shares in Q2 2026, an estimated $2.02M.
  • Boston Scientific made up 0.97% of Foresight Group's portfolio in Q2 2026, its #36 holding.
  • Foresight Group first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Foresight Group's Boston Scientific position peaked at $5.61M in Q1 2026.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Foresight Group's 13F filing for Q2 2026, filed 27 Jul 2026.